{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:10:57Z","timestamp":1793689857019,"version":"4.5.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T00:00:00Z","timestamp":1750204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HL136275"],"award-info":[{"award-number":["HL136275"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["HL145241"],"award-info":[{"award-number":["HL145241"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cardiovasc Res"],"DOI":"10.1038\/s44161-025-00671-9","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T05:02:43Z","timestamp":1750222963000},"page":"841-856","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Loss of effector Treg signature in APOB-reactive CD4+ T cells in patients with coronary artery disease"],"prefix":"10.1038","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2511-068X","authenticated-orcid":false,"given":"Payel","family":"Roy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0605-1063","authenticated-orcid":false,"given":"Anusha","family":"Bellapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujit Silas Armstrong","family":"Suthahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Oliaeimotlagh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingkang","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6348-2612","authenticated-orcid":false,"given":"Smriti","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Makings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runpei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megh","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin W. T.","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7013-2250","authenticated-orcid":false,"given":"Alessandro","family":"Sette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0049-9986","authenticated-orcid":false,"given":"Coleen A.","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9339-3672","authenticated-orcid":false,"given":"Klaus","family":"Ley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,18]]},"reference":[{"key":"671_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","volume":"5","author":"P Libby","year":"2019","unstructured":"Libby, P. et al. Atherosclerosis. Nat. Rev. Dis. Primers 5, 56 (2019).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"671_CR2","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/01.ATV.6.2.131","volume":"6","author":"L Jonasson","year":"1986","unstructured":"Jonasson, L., Holm, J., Skalli, O., Bondjers, G. & Hansson, G. K. Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis 6, 131\u2013138 (1986).","journal-title":"Arteriosclerosis"},{"key":"671_CR3","first-page":"191","volume":"125","author":"AM Gown","year":"1986","unstructured":"Gown, A. M., Tsukada, T. & Ross, R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Pathol. 125, 191\u2013207 (1986).","journal-title":"Am. J. Pathol."},{"key":"671_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","volume":"22","author":"P Roy","year":"2022","unstructured":"Roy, P., Orecchioni, M. & Ley, K. How the immune system shapes atherosclerosis: roles of innate and adaptive immunity. Nat. Rev. Immunol. 22, 251\u2013265 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"671_CR5","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/s41591-019-0590-4","volume":"25","author":"DM Fernandez","year":"2019","unstructured":"Fernandez, D. M. et al. Single-cell immune landscape of human atherosclerotic plaques. Nat. Med. 25, 1576\u20131588 (2019).","journal-title":"Nat. Med."},{"key":"671_CR6","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s44161-022-00208-4","volume":"2","author":"MAC Depuydt","year":"2023","unstructured":"Depuydt, M. A. C. et al. Single-cell T cell receptor sequencing of paired human atherosclerotic plaques and blood reveals autoimmune-like features of expanded effector T cells. Nat. Cardiovasc. Res. 2, 112\u2013125 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"671_CR7","doi-asserted-by":"publisher","first-page":"2752","DOI":"10.1172\/JCI119465","volume":"99","author":"S Gupta","year":"1997","unstructured":"Gupta, S. et al. IFN-\u03b3 potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99, 2752\u20132761 (1997).","journal-title":"J. Clin. Invest."},{"key":"671_CR8","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1073\/pnas.0409015102","volume":"102","author":"C Buono","year":"2005","unstructured":"Buono, C. et al. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc. Natl Acad. Sci. USA 102, 1596\u20131601 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"671_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1161\/01.ATV.0000059419.11002.6E","volume":"23","author":"C Buono","year":"2003","unstructured":"Buono, C. et al. Influence of interferon-\u03b3 on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 23, 454\u2013460 (2003).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"671_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1161\/01.CIR.104.2.197","volume":"104","author":"E Laurat","year":"2001","unstructured":"Laurat, E. et al. In vivo downregulation of T helper cell 1 immune responses reduces atherogenesis in apolipoprotein E-knockout mice. Circulation 104, 197\u2013202 (2001).","journal-title":"Circulation"},{"key":"671_CR11","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nm1343","volume":"12","author":"H Ait-Oufella","year":"2006","unstructured":"Ait-Oufella, H. et al. Natural regulatory T cells control the development of atherosclerosis in mice. Nat. Med. 12, 178\u2013180 (2006).","journal-title":"Nat. Med."},{"key":"671_CR12","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1172\/JCI63891","volume":"123","author":"R Klingenberg","year":"2013","unstructured":"Klingenberg, R. et al. Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis. J. Clin. Invest. 123, 1323\u20131334 (2013).","journal-title":"J. Clin. Invest."},{"key":"671_CR13","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1161\/01.ATV.0000259365.31469.89","volume":"27","author":"A Mor","year":"2007","unstructured":"Mor, A. et al. Role of naturally occurring CD4+CD25+ regulatory T cells in experimental atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 27, 893\u2013900 (2007).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"671_CR14","doi-asserted-by":"publisher","first-page":"e17","DOI":"10.1161\/01.RES.85.8.e17","volume":"85","author":"Z Mallat","year":"1999","unstructured":"Mallat, Z. et al. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85, e17\u2013e24 (1999).","journal-title":"Circ. Res."},{"key":"671_CR15","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1172\/JCI18607","volume":"112","author":"A-KL Robertson","year":"2003","unstructured":"Robertson, A.-K. L. et al. Disruption of TGF-\u03b2 signaling in T cells accelerates atherosclerosis. J. Clin. Invest. 112, 1342\u20131350 (2003).","journal-title":"J. Clin. Invest."},{"key":"671_CR16","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1093\/eurheartj\/ehl222","volume":"27","author":"A Mor","year":"2006","unstructured":"Mor, A., Luboshits, G., Planer, D., Keren, G. & George, J. Altered status of CD4+CD25+ regulatory T cells in patients with acute coronary syndromes. Eur. Heart J. 27, 2530\u20132537 (2006).","journal-title":"Eur. Heart J."},{"key":"671_CR17","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1159\/000358639","volume":"33","author":"K Meng","year":"2014","unstructured":"Meng, K. et al. Impairment of circulating CD4+CD25+GARP+ regulatory T cells in patients with acute coronary syndrome. Cell. Physiol. Biochem. 33, 621\u2013632 (2014).","journal-title":"Cell. Physiol. Biochem."},{"key":"671_CR18","doi-asserted-by":"publisher","first-page":"e88775","DOI":"10.1371\/journal.pone.0088775","volume":"9","author":"Z-F Zhu","year":"2014","unstructured":"Zhu, Z.-F. et al. Impaired circulating CD4+LAP+ regulatory T cells in patients with acute coronary syndrome and its mechanistic study. PLoS ONE 9, e88775 (2014).","journal-title":"PLoS ONE"},{"key":"671_CR19","doi-asserted-by":"publisher","first-page":"e72804","DOI":"10.1371\/journal.pone.0072804","volume":"8","author":"Y Ma","year":"2013","unstructured":"Ma, Y. et al. Imbalanced frequencies of Th17 and Treg cells in acute coronary syndromes are mediated by IL-6-STAT3 signaling. PLoS ONE 8, e72804 (2013).","journal-title":"PLoS ONE"},{"key":"671_CR20","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.clim.2007.03.546","volume":"124","author":"SF Han","year":"2007","unstructured":"Han, S. F. et al. The opposite-direction modulation of CD4+CD25+ Tregs and T helper 1 cells in acute coronary syndromes. Clin. Immunol. 124, 90\u201397 (2007).","journal-title":"Clin. Immunol."},{"key":"671_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","volume":"127","author":"X Cheng","year":"2008","unstructured":"Cheng, X. et al. The Th17\/Treg imbalance in patients with acute coronary syndrome. Clin. Immunol. 127, 89\u201397 (2008).","journal-title":"Clin. Immunol."},{"key":"671_CR22","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1161\/ATVBAHA.110.206813","volume":"30","author":"E Ammirati","year":"2010","unstructured":"Ammirati, E. et al. Circulating CD4+CD25hiCD127lo regulatory T-cell levels do not reflect the extent or severity of carotid and coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 30, 1832\u20131841 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"671_CR23","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1161\/CIRCRESAHA.121.320090","volume":"130","author":"RR Chowdhury","year":"2022","unstructured":"Chowdhury, R. R. et al. Human coronary plaque T cells are clonal and cross-react to virus and self. Circ. Res. 130, 1510\u20131530 (2022).","journal-title":"Circ. Res."},{"key":"671_CR24","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1073\/pnas.92.9.3893","volume":"92","author":"S Stemme","year":"1995","unstructured":"Stemme, S. et al. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl Acad. Sci. USA 92, 3893\u20133897 (1995).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"671_CR25","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1161\/01.CIR.102.10.1114","volume":"102","author":"G Caligiuri","year":"2000","unstructured":"Caligiuri, G., Paulsson, G., Nicoletti, A., Maseri, A. & Hansson, G. K. Evidence for antigen-driven T-cell response in unstable angina. Circulation 102, 1114\u20131119 (2000).","journal-title":"Circulation"},{"key":"671_CR26","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1084\/jem.20092243","volume":"207","author":"A Hermansson","year":"2010","unstructured":"Hermansson, A. et al. Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis. J. Exp. Med. 207, 1081\u20131093 (2010).","journal-title":"J. Exp. Med."},{"key":"671_CR27","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1161\/CIRCULATIONAHA.118.034076","volume":"138","author":"A Gistera","year":"2018","unstructured":"Gistera, A. et al. Low-density lipoprotein-reactive T cells regulate plasma cholesterol levels and development of atherosclerosis in humanized hypercholesterolemic mice. Circulation 138, 2513\u20132526 (2018).","journal-title":"Circulation"},{"key":"671_CR28","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1097\/MOL.0b013e328356ec7c","volume":"23","author":"J Nilsson","year":"2012","unstructured":"Nilsson, J., Bjorkbacka, H. & Fredrikson, G. N. Apolipoprotein B100 autoimmunity and atherosclerosis\u2014disease mechanisms and therapeutic potential. Curr. Opin. Lipidol. 23, 422\u2013428 (2012).","journal-title":"Curr. Opin. Lipidol."},{"key":"671_CR29","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41577-024-01010-y","volume":"24","author":"A Khan","year":"2024","unstructured":"Khan, A., Roy, P. & Ley, K. Breaking tolerance: the autoimmune aspect of atherosclerosis. Nat. Rev. Immunol. 24, 670\u2013679 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"671_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCRESAHA.122.321116","volume":"131","author":"P Roy","year":"2022","unstructured":"Roy, P. et al. Immunodominant MHC-II (major histocompatibility complex II) restricted epitopes in human apolipoprotein B. Circ. Res. 131, 258\u2013276 (2022).","journal-title":"Circ. Res."},{"key":"671_CR31","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1161\/CIRCULATIONAHA.119.042863","volume":"142","author":"D Wolf","year":"2020","unstructured":"Wolf, D. et al. Pathogenic autoimmunity in atherosclerosis evolves from initially protective apolipoprotein B100-reactive CD4+ T-regulatory cells. Circulation 142, 1279\u20131293 (2020).","journal-title":"Circulation"},{"key":"671_CR32","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1161\/CIRCULATIONAHA.117.031420","volume":"138","author":"T Kimura","year":"2018","unstructured":"Kimura, T. et al. Regulatory CD4+ T cells recognize MHC-II-restricted peptide epitopes of apolipoprotein B. Circulation 138, 1130\u20131143 (2018).","journal-title":"Circulation"},{"key":"671_CR33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s44161-022-00063-3","volume":"1","author":"R Saigusa","year":"2022","unstructured":"Saigusa, R. et al. Single cell transcriptomics and TCR reconstruction reveal CD4 T cell response to MHC-II-restricted APOB epitope in human cardiovascular disease. Nat. Cardiovasc. Res. 1, 462\u2013475 (2022).","journal-title":"Nat. Cardiovasc. Res."},{"key":"671_CR34","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.cell.2016.09.050","volume":"167","author":"P Bacher","year":"2016","unstructured":"Bacher, P. et al. Regulatory T cell specificity directs tolerance versus allergy against aeroantigens in humans. Cell 167, 1067\u20131078 (2016).","journal-title":"Cell"},{"key":"671_CR35","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.cell.2020.10.001","volume":"183","author":"BJ Meckiff","year":"2020","unstructured":"Meckiff, B. J. et al. Imbalance of regulatory and cytotoxic SARS-CoV-2-reactive CD4+ T cells in COVID-19. Cell 183, 1340\u20131353 (2020).","journal-title":"Cell"},{"key":"671_CR36","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.jhep.2020.05.053","volume":"73","author":"A Renand","year":"2020","unstructured":"Renand, A. et al. Integrative molecular profiling of autoreactive CD4 T cells in autoimmune hepatitis. J. Hepatol. 73, 1379\u20131390 (2020).","journal-title":"J. Hepatol."},{"key":"671_CR37","doi-asserted-by":"publisher","first-page":"e0186998","DOI":"10.1371\/journal.pone.0186998","volume":"12","author":"S Reiss","year":"2017","unstructured":"Reiss, S. et al. Comparative analysis of activation induced marker (AIM) assays for sensitive identification of antigen-specific CD4 T cells. PLoS ONE 12, e0186998 (2017).","journal-title":"PLoS ONE"},{"key":"671_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2023.100690","volume":"4","author":"A Lemieux","year":"2024","unstructured":"Lemieux, A. et al. Enhanced detection of antigen-specific T cells by a multiplexed AIM assay. Cell Rep. Methods 4, 100690 (2024).","journal-title":"Cell Rep. Methods"},{"key":"671_CR39","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1161\/xJAHA.111.000125","volume":"1","author":"E Ammirati","year":"2012","unstructured":"Ammirati, E. et al. Effector memory T cells are associated with atherosclerosis in humans and animal models. J. Am. Heart Assoc. 1, 27\u201341 (2012).","journal-title":"J. Am. Heart Assoc."},{"key":"671_CR40","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1177\/1479164118817942","volume":"16","author":"S Rattik","year":"2019","unstructured":"Rattik, S. et al. Elevated circulating effector memory T cells but similar levels of regulatory T cells in patients with type 2 diabetes mellitus and cardiovascular disease. Diab. Vasc. Dis. Res. 16, 270\u2013280 (2019).","journal-title":"Diab. Vasc. Dis. Res."},{"key":"671_CR41","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41590-024-02021-6","volume":"26","author":"FS Nettersheim","year":"2025","unstructured":"Nettersheim, F. S. et al. PD-1 and CD73 on naive CD4+ T cells synergistically limit responses to self. Nat. Immunol. 26, 105\u2013115 (2025).","journal-title":"Nat. Immunol."},{"key":"671_CR42","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/j.cell.2018.10.022","volume":"175","author":"BJ Schmiedel","year":"2018","unstructured":"Schmiedel, B. J. et al. Impact of genetic polymorphisms on human immune cell gene expression. Cell 175, 1701\u20131715 (2018).","journal-title":"Cell"},{"key":"671_CR43","doi-asserted-by":"publisher","first-page":"585","DOI":"10.4049\/immunohorizons.2000037","volume":"4","author":"B H\u00f6llbacher","year":"2020","unstructured":"H\u00f6llbacher, B. et al. Transcriptomic profiling of human effector and regulatory T cell subsets identifies predictive population signatures. Immunohorizons 4, 585\u2013596 (2020).","journal-title":"Immunohorizons"},{"key":"671_CR44","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/cmi.2014.134","volume":"12","author":"M Attaf","year":"2015","unstructured":"Attaf, M., Huseby, E. & Sewell, A. K. \u03b1\u03b2 T cell receptors as predictors of health and disease. Cell Mol. Immunol. 12, 391\u2013399 (2015).","journal-title":"Cell Mol. Immunol."},{"key":"671_CR45","doi-asserted-by":"publisher","first-page":"1302031","DOI":"10.3389\/fimmu.2024.1302031","volume":"15","author":"P Roy","year":"2024","unstructured":"Roy, P., Suthahar, S. S. A., Makings, J. & Ley, K. Identification of apolipoprotein B\u2013reactive CDR3 motifs allows tracking of atherosclerosis-related memory CD4+T cells in multiple donors. Front. Immunol. 15, 1302031 (2024).","journal-title":"Front. Immunol."},{"key":"671_CR46","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.it.2012.01.002","volume":"33","author":"Y Ding","year":"2012","unstructured":"Ding, Y., Xu, J. & Bromberg, J. S. Regulatory T cell migration during an immune response. Trends Immunol. 33, 174\u2013180 (2012).","journal-title":"Trends Immunol."},{"key":"671_CR47","doi-asserted-by":"publisher","first-page":"301","DOI":"10.4049\/jimmunol.178.1.301","volume":"178","author":"JH Lee","year":"2007","unstructured":"Lee, J. H., Kang, S. G. & Kim, C. H. FoxP3+ T cells undergo conventional first switch to lymphoid tissue homing receptors in thymus but accelerated second switch to nonlymphoid tissue homing receptors in secondary lymphoid tissues. J. Immunol. 178, 301\u2013311 (2007).","journal-title":"J. Immunol."},{"key":"671_CR48","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1084\/jem.194.6.847","volume":"194","author":"A Iellem","year":"2001","unstructured":"Iellem, A. et al. Unique chemotactic response profile and specific expression of chemokine receptors CCR4 and CCR8 by CD4+CD25+ regulatory T cells. J. Exp. Med. 194, 847\u2013853 (2001).","journal-title":"J. Exp. Med."},{"key":"671_CR49","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.immuni.2021.03.007","volume":"54","author":"M Delacher","year":"2021","unstructured":"Delacher, M. et al. Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells. Immunity 54, 702\u2013720 (2021).","journal-title":"Immunity"},{"key":"671_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.xgen.2023.100473","volume":"4","author":"Y Yasumizu","year":"2024","unstructured":"Yasumizu, Y. et al. Single-cell transcriptome landscape of circulating CD4+ T cell populations in autoimmune diseases. Cell Genom. 4, 100473 (2024).","journal-title":"Cell Genom."},{"key":"671_CR51","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.it.2005.10.001","volume":"26","author":"J Huehn","year":"2005","unstructured":"Huehn, J. & Hamann, A. Homing to suppress: address codes for Treg migration. Trends Immunol. 26, 632\u2013636 (2005).","journal-title":"Trends Immunol."},{"key":"671_CR52","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1161\/CIRCRESAHA.116.308648","volume":"118","author":"J Li","year":"2016","unstructured":"Li, J. et al. CCR5+T-bet+FoxP3+ effector CD4 T cells drive atherosclerosis. Circ. Res. 118, 1540\u20131552 (2016).","journal-title":"Circ. Res."},{"key":"671_CR53","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1161\/CIRCULATIONAHA.106.678474","volume":"116","author":"E Galkina","year":"2007","unstructured":"Galkina, E. et al. CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-\u03b3 production, and macrophage accumulation in the aortic wall. Circulation 116, 1801\u20131811 (2007).","journal-title":"Circulation"},{"key":"671_CR54","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/nri722","volume":"2","author":"AEI Proudfoot","year":"2002","unstructured":"Proudfoot, A. E. I. Chemokine receptors: multifaceted therapeutic targets. Nat. Rev. Immunol. 2, 106\u2013115 (2002).","journal-title":"Nat. Rev. Immunol."},{"key":"671_CR55","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1038\/s41590-023-01589-9","volume":"24","author":"A Freuchet","year":"2023","unstructured":"Freuchet, A. et al. Identification of human exTreg cells as CD16+CD56+ cytotoxic CD4+ T cells. Nat. Immunol. 24, 1748\u20131761 (2023).","journal-title":"Nat. Immunol."},{"key":"671_CR56","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s44161-023-00218-w","volume":"2","author":"Z Wang","year":"2023","unstructured":"Wang, Z. et al. Pairing of single-cell RNA analysis and T cell antigen receptor profiling indicates breakdown of T cell tolerance checkpoints in atherosclerosis. Nat. Cardiovasc. Res. 2, 290\u2013306 (2023).","journal-title":"Nat. Cardiovasc. Res."},{"key":"671_CR57","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.it.2012.11.002","volume":"34","author":"E Cretney","year":"2013","unstructured":"Cretney, E., Kallies, A. & Nutt, S. L. Differentiation and function of Foxp3+ effector regulatory T cells. Trends Immunol. 34, 74\u201380 (2013).","journal-title":"Trends Immunol."},{"key":"671_CR58","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1084\/jem.20031562","volume":"199","author":"J Huehn","year":"2004","unstructured":"Huehn, J. et al. Developmental stage, phenotype, and migration distinguish naive- and effector\/memory-like CD4+ regulatory T cells. J. Exp. Med. 199, 303\u2013313 (2004).","journal-title":"J. Exp. Med."},{"key":"671_CR59","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24213-6","volume":"12","author":"Y Luo","year":"2021","unstructured":"Luo, Y. et al. Single-cell transcriptomic analysis reveals disparate effector differentiation pathways in human Treg compartment. Nat. Commun. 12, 3913 (2021).","journal-title":"Nat. Commun."},{"key":"671_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22975-7","volume":"12","author":"G Mijnheer","year":"2021","unstructured":"Mijnheer, G. et al. Conserved human effector Treg cell transcriptomic and epigenetic signature in arthritic joint inflammation. Nat. Commun. 12, 2710 (2021).","journal-title":"Nat. Commun."},{"key":"671_CR61","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1038\/s41590-020-0769-3","volume":"21","author":"S Kumagai","year":"2020","unstructured":"Kumagai, S. et al. The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies. Nat. Immunol. 21, 1346\u20131358 (2020).","journal-title":"Nat. Immunol."},{"key":"671_CR62","doi-asserted-by":"publisher","first-page":"9999","DOI":"10.1073\/pnas.1822001116","volume":"116","author":"T Kamada","year":"2019","unstructured":"Kamada, T. et al. PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer. Proc. Natl Acad. Sci. USA 116, 9999\u201310008 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"671_CR63","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20182232","volume":"218","author":"CL Tan","year":"2021","unstructured":"Tan, C. L. et al. PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance. J. Exp. Med. 218, e20182232 (2021).","journal-title":"J. Exp. Med."},{"key":"671_CR64","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nri2916","volume":"11","author":"DJ Campbell","year":"2011","unstructured":"Campbell, D. J. & Koch, M. A. Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 11, 119\u2013130 (2011).","journal-title":"Nat. Rev. Immunol."},{"key":"671_CR65","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.4049\/jimmunol.1601409","volume":"198","author":"Z Zhang","year":"2017","unstructured":"Zhang, Z. et al. Activation and functional specialization of regulatory T cells lead to the generation of Foxp3 instability. J. Immunol. 198, 2612\u20132625 (2017).","journal-title":"J. Immunol."},{"key":"671_CR66","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abm2508","volume":"7","author":"BJ Schmiedel","year":"2022","unstructured":"Schmiedel, B. J. et al. Single-cell eQTL analysis of activated T cell subsets reveals activation and cell type\u2013dependent effects of disease-risk variants. Sci. Immunol. 7, eabm2508 (2022).","journal-title":"Sci. Immunol."},{"key":"671_CR67","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.it.2014.08.003","volume":"36","author":"H Zeng","year":"2015","unstructured":"Zeng, H. & Chi, H. Metabolic control of regulatory T cell development and function. Trends Immunol. 36, 3\u201312 (2015).","journal-title":"Trends Immunol."},{"key":"671_CR68","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1161\/ATVBAHA.119.312287","volume":"40","author":"TX Zhao","year":"2020","unstructured":"Zhao, T. X., Newland, S. A. & Mallat, Z. 2019 ATVB Plenary Lecture: Interleukin-2 therapy in cardiovascular disease: the potential to regulate innate and adaptive immunity. Arterioscler. Thromb. Vasc. Biol. 40, 853\u2013864 (2020).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"671_CR69","doi-asserted-by":"publisher","first-page":"102827","DOI":"10.1016\/j.ebiom.2020.102827","volume":"57","author":"FL Vigario","year":"2020","unstructured":"Vigario, F. L., Kuiper, J. & Slutter, B. Tolerogenic vaccines for the treatment of cardiovascular diseases. eBioMedicine 57, 102827 (2020).","journal-title":"eBioMedicine"},{"key":"671_CR70","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2100009","volume":"1","author":"TX Zhao","year":"2022","unstructured":"Zhao, T. X. et al. Regulatory T-cell response to low-dose interleukin-2 in ischemic heart disease. NEJM Evid. 1, EVIDoa2100009 (2022).","journal-title":"NEJM Evid."},{"key":"671_CR71","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.immuni.2023.01.004","volume":"56","author":"S Dikiy","year":"2023","unstructured":"Dikiy, S. & Rudensky, A. Y. Principles of regulatory T cell function. Immunity 56, 240\u2013255 (2023).","journal-title":"Immunity"},{"key":"671_CR72","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20231244","volume":"221","author":"LF Loffredo","year":"2024","unstructured":"Loffredo, L. F., Savage, T. M., Ringham, O. R. & Arpaia, N. Treg\u2013tissue cell interactions in repair and regeneration. J. Exp. Med. 221, e20231244 (2024).","journal-title":"J. Exp. Med."},{"key":"671_CR73","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/s44161-023-00376-x","volume":"2","author":"I Raposo-Guti\u00e9rrez","year":"2023","unstructured":"Raposo-Guti\u00e9rrez, I., Rodr\u00edguez-Ronchel, A. & Ramiro, A. R. Atherosclerosis antigens as targets for immunotherapy. Nat. Cardiovasc. Res. 2, 1129\u20131147 (2023).","journal-title":"Nat. Cardiovasc. Res."}],"container-title":["Nature Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00671-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00671-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00671-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T21:09:44Z","timestamp":1757192984000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44161-025-00671-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,18]]},"references-count":73,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["671"],"URL":"https:\/\/doi.org\/10.1038\/s44161-025-00671-9","relation":{},"ISSN":["2731-0590"],"issn-type":[{"value":"2731-0590","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,18]]},"assertion":[{"value":"16 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"K.L. is the founder and co-owner of Atherovax, Inc. He receives no compensation from Atherovax. No Atherovax funds were used in this study. K.L. and P.R. are named as co-inventors on a patent application (provisional application no. 63\/789,764, filed by the La Jolla Institute for Immunology, approval status pending) that is related to the use of human APOB epitopes and related methods in modulating inflammatory responses and treating adverse cardiovascular events, disease and atherosclerosis. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}